Clinical Trials
2 trialsNCT03737994 2026-04-23
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT05100069 2026-03-17
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
Takeda
Recruiting